Jeremy Allred, MD

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation

Jeremy Allred

Contact Info

Administrative Assistant Name
Kris Blomquist

Administrative Phone
612-625-8942

Administrative Email
krblomqu@umn.edu

Administrative Fax Number
612-625-6919

Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation


Hematologist


MD, Medical College of Wisconsin, Milwaukee, WI

Residency, University of Minnesota, Minneapolis, MN

Fellowship, University of Minnesota, Minneapolis, MN

Summary

Dr. Allred is an Assistant Professor of Medicine in the Division of Hematology, Oncology and Transplantation where he serves as an oncologist with a focus on the treatment of blood cancers. In addition to his clinical interests, Dr. Allred has an active clinical and translational research effort that includes cutting edge basic science into the biology of myeloid cancer development and its interaction with the immune system. The goal of this work is to develop next generation targeted therapies, including immune and cellular therapies, to improve the treatment of myeloid cancers and improve the lives of patients with these diseases.

Expertise

  • Malignant Hematology
  • Cell Therapy
  • Immunology
  • Basic Science Research

Awards & Recognition

  • HHMI Medical Research Fellow (2012)
  • Ruth L. Kirschstein National Research Service Award (2017)
  • Minnesota Society of Clinical Oncology Outstanding Fellow Award (2020, 2021)
  • American Society of Hematology Research Training Award for Fellows (2021)

Professional Associations

  • American Society of Hematology
  • American Association of Immunologists
  • American Society of Transplantation and Cellular Therapy
  • American Society of Gene and Cell Therapy

Research

Research Summary/Interests

  • Immunology of Cancer
  • Bone Marrow Transplant and Cellular Therapy
  • Immune Therapy
  • Stem Cell Biology
  • Developmental Hematopoiesis

Clinical

Clinical Interests

Myeloid Neoplasms; Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chimeric Antigen Receptor T Cell Therapy; Bone Marrow Transplantation